JP2010504301A5 - - Google Patents

Download PDF

Info

Publication number
JP2010504301A5
JP2010504301A5 JP2009528719A JP2009528719A JP2010504301A5 JP 2010504301 A5 JP2010504301 A5 JP 2010504301A5 JP 2009528719 A JP2009528719 A JP 2009528719A JP 2009528719 A JP2009528719 A JP 2009528719A JP 2010504301 A5 JP2010504301 A5 JP 2010504301A5
Authority
JP
Japan
Prior art keywords
cycloalkyl
attached
compound according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009528719A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010504301A (ja
Filing date
Publication date
Priority claimed from GB0618776A external-priority patent/GB0618776D0/en
Priority claimed from GB0704012A external-priority patent/GB0704012D0/en
Priority claimed from GB0717170A external-priority patent/GB0717170D0/en
Application filed filed Critical
Priority claimed from PCT/EP2007/059933 external-priority patent/WO2008034860A1/en
Publication of JP2010504301A publication Critical patent/JP2010504301A/ja
Publication of JP2010504301A5 publication Critical patent/JP2010504301A5/ja
Pending legal-status Critical Current

Links

JP2009528719A 2006-09-22 2007-09-20 Ikk2阻害物質としてのピロロ[2,3−b]ピリジン−4−イル−ベンゼンスルホンアミド化合物 Pending JP2010504301A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0618776A GB0618776D0 (en) 2006-09-22 2006-09-22 Novel compounds
GB0704012A GB0704012D0 (en) 2007-03-01 2007-03-01 Novel compounds
GB0717170A GB0717170D0 (en) 2007-09-04 2007-09-04 Novelcompounds
PCT/EP2007/059933 WO2008034860A1 (en) 2006-09-22 2007-09-20 Pyrrolo[2, 3-b]pyridin-4-yl-benzenesulfonamide compounds as ikk2 inhibitors

Publications (2)

Publication Number Publication Date
JP2010504301A JP2010504301A (ja) 2010-02-12
JP2010504301A5 true JP2010504301A5 (OSRAM) 2010-11-18

Family

ID=39092148

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009528719A Pending JP2010504301A (ja) 2006-09-22 2007-09-20 Ikk2阻害物質としてのピロロ[2,3−b]ピリジン−4−イル−ベンゼンスルホンアミド化合物

Country Status (11)

Country Link
US (3) US20080176891A1 (OSRAM)
EP (1) EP2069341B1 (OSRAM)
JP (1) JP2010504301A (OSRAM)
AR (1) AR062928A1 (OSRAM)
AT (1) ATE493411T1 (OSRAM)
CL (1) CL2007002708A1 (OSRAM)
DE (1) DE602007011645D1 (OSRAM)
PE (1) PE20080925A1 (OSRAM)
TW (1) TW200836724A (OSRAM)
UY (1) UY30600A1 (OSRAM)
WO (1) WO2008034860A1 (OSRAM)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0400895D0 (en) * 2004-01-15 2004-02-18 Smithkline Beecham Corp Chemical compounds
AR050253A1 (es) * 2004-06-24 2006-10-11 Smithkline Beecham Corp Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
AR065804A1 (es) 2007-03-23 2009-07-01 Smithkline Beecham Corp Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
GB0804592D0 (en) * 2008-03-12 2008-04-16 Glaxo Group Ltd Novel compounds
GB0804591D0 (en) * 2008-03-12 2008-04-16 Glaxo Group Ltd Novel compounds
US8642069B2 (en) * 2008-08-27 2014-02-04 Alexander D. Goldin Composition and method for treating colds
US8354539B2 (en) 2009-03-10 2013-01-15 Glaxo Group Limited Indole derivatives as IKK2 inhibitors
US8754114B2 (en) 2010-12-22 2014-06-17 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
US8877742B2 (en) 2011-06-10 2014-11-04 Glaxosmithkline Intellectual Property Limited Compounds
PE20190736A1 (es) 2012-06-13 2019-05-23 Incyte Holdings Corp Compuestos triciclicos sustituidos como inhibidores del receptor del factor de crecimiento de fibroblastos (fgfr)
WO2014026125A1 (en) 2012-08-10 2014-02-13 Incyte Corporation Pyrazine derivatives as fgfr inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
UY35419A (es) * 2013-03-14 2014-10-31 Abbvie Inc Inhibidores de cdk9 quinasa de pirrolo (2,3- b) piridina
JP2016514113A (ja) * 2013-03-14 2016-05-19 アッヴィ・インコーポレイテッド ピロロ[2,3−b]ピリジンcdk9キナーゼ阻害剤
KR102269032B1 (ko) 2013-04-19 2021-06-24 인사이트 홀딩스 코포레이션 Fgfr 저해제로서 이환식 헤테로사이클
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
ES2895769T3 (es) 2015-02-20 2022-02-22 Incyte Corp Heterociclos bicíclicos como inhibidores de FGFR
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
SI3788047T1 (sl) 2018-05-04 2024-11-29 Incyte Corporation Trdne oblike inhibitorja fgfr in postopki priprave le-teh
SG11202010882XA (en) 2018-05-04 2020-11-27 Incyte Corp Salts of an fgfr inhibitor
WO2020185532A1 (en) 2019-03-08 2020-09-17 Incyte Corporation Methods of treating cancer with an fgfr inhibitor
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2021067374A1 (en) 2019-10-01 2021-04-08 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
US11607416B2 (en) 2019-10-14 2023-03-21 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2021113462A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Derivatives of an fgfr inhibitor
EP4069696A1 (en) 2019-12-04 2022-10-12 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
WO2021146424A1 (en) 2020-01-15 2021-07-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2022221170A1 (en) 2021-04-12 2022-10-20 Incyte Corporation Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
WO2022261159A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
WO2022261160A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
CN114210133B (zh) * 2021-12-13 2023-01-24 广德辉龙环保科技有限公司 一种抗紫外线过滤袋及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2460680A1 (en) * 2001-09-19 2003-05-01 Pharmacia Corporation Substituted indazole compounds for the treatment of inflammation
GB0308466D0 (en) * 2003-04-11 2003-05-21 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2010504301A5 (OSRAM)
JP2009524695A5 (OSRAM)
JP2010524750A5 (OSRAM)
JP2010505891A5 (OSRAM)
JP2010518805A5 (OSRAM)
JP2010538767A5 (OSRAM)
JP2012507448A5 (OSRAM)
JP2010500116A5 (OSRAM)
JP2011526809A5 (OSRAM)
JP2010505027A5 (OSRAM)
JP2009149903A5 (OSRAM)
JP2006524283A5 (OSRAM)
JP2011528458A5 (OSRAM)
JP2010514554A5 (OSRAM)
JP2011508438A5 (OSRAM)
JP2011501007A5 (OSRAM)
ATE554604T1 (de) Verbesserter ohrhörer
JP2012065100A5 (OSRAM)
JP2011520976A5 (OSRAM)
JP2010521616A5 (OSRAM)
JP2010529364A5 (OSRAM)
JP2009536652A5 (OSRAM)
JP2013501834A5 (OSRAM)
JP2013529123A5 (OSRAM)
JP2015518492A5 (OSRAM)